This event has ended.
CANCEL
Open for everyone
research
- 22:00 CRI - 8bis rue Charles V, 75004 Paris

Biotech Start-up Series #1: Synthetic Biology, application to the pharmaceutical industry

REGISTER
Biotech Start-up Series #1: Synthetic Biology, application to the pharmaceutical industry

The Biotech Start-up Series of conferences focuses on entrepreneurship in healthcare, joining American & European entrepreneurs, researchers and experts as we gather to explore trends in the biotechnology field. In this first event we will focus on the new tools of Synthetic Biology, with the potential to significantly impact tomorrow's medicine.

Come hear from impassioned specialists about their current research and learn about the challenges in bringing new technologies to bear on medical practice. Can synthetic biology save lives? Will it? What will it take?

BioLabs, the leading operator of co-working laboratory spaces in the US, in collaboration with Servier, a global pharmaceutical company governed by a Foundation, is pleased to invite you to this free event happening in the hub of research and innovation in Paris, the CRI.

For this first event we are very pleased to announce the following speakers:

  • François Képès, Ph.D.

Académie des Technologies, founder of the Institut de Biologie des Systèmes et de Synthèse (iSSB), former CNRS director and serial-entrepreneur,

  • Oscar Castanon, Ph.D.

Post-doctoral researcher at George Church's Laboratory, Harvard Medical School

  • Catherine Boule

Managing Partner, Cap Decisif, Healthcare practice,

  • Aurélie Grienenberger, Ph.D.

Chief Business Officer, EligoBiosciences,

  • Alexandre LeBeaut, MD

Former Vice-President R&D and CSO, Ipsen,

  • Hélène Tran, Ph.D.

Project Leader Neurology, Servier R&D.

The conference will be followed by a cocktail and networking session. We look forward to meeting with you at CRI amphitheater on March 5th!

Free event. Open for everyone, limited seating.

For more information: www.biolabs.io


Upcoming events...

CRI

Candidature Licence Frontières du Vivant

Candidature Licence Frontières du Vivant

CRI

MOOC BIG - BIOINFORMATIQUE POUR LA GÉNÉTIQUE MÉDICALE

MOOC BIG - BIOINFORMATIQUE POUR LA GÉNÉTIQUE MÉDICALE

CRI

Prendre soin : tous humains ? par Dr Marie-Aude Piot

Prendre soin : tous humains ? par Dr Marie-Aude Piot

8 bis rue Charles V

ECO-ART NIGHT

ECO-ART NIGHT

ONLINE

Méditation soignants - online - samedi 4/04

Méditation soignants - online - samedi 4/04

CRI Lounge

Panier d'Alexandre: Communal Dinner & Seasonal Food Workshop

Panier d'Alexandre: Communal Dinner & Seasonal Food Workshop

Sorbonne Université - Campus Jussieu (exact room and building within the Jussieu Campus will be specified at a later date)

The 2ndInternational Colloquium on Network and Evolution, April 24th, Sorbonne Université, Paris France (Free but registration strongly encouraged)

crilogo

CRI

[ANNULÉ] Transition écologique : que peut l'école ?

[ANNULÉ] Transition écologique : que peut l'école ?

CRI

Art in the Age of Digital Reproduction - PCA Student Symposium

Art in the Age of Digital Reproduction - PCA Student Symposium

CRI Learning Center Extension

CRI Research seminar - Kirstie Whitaker – Participatory citizen science to improve autistic people's lives

CRI Research seminar - Kirstie Whitaker – Participatory citizen science to improve autistic people's lives

CRI

Les directives anticipées et la planification anticipée des soins par Gian Domenico Borasio

Les directives anticipées et la planification anticipée des soins par Gian Domenico Borasio

CRI

Congrès des élèves chercheurs Savanturiers 2020 - Édition parisienne

crilogo

CRI

Euthanasie, suicide assisté et loi Leonetti: l’évidence scientifique par Gian Domenico Borasio

Euthanasie, suicide assisté et loi Leonetti: l’évidence scientifique par Gian Domenico Borasio

CRI

Université d'été de l'éducation par la recherche #2

crilogo

CRI - 8 bis rue Charles V, 75004 Paris

Biotech Start-up Series #2: Oncology Markets, implications for Product Development and Deal-Making

Biotech Start-up Series #2: Oncology Markets, implications for Product Development and Deal-Making